← The Feline Tritrichomonas ProjectPrintable sheet · prints to one page · all printables
The Feline Tritrichomonas Project · consult summary · 27 Oct 2026

Feline trichomonosis — what to test, what was dosed, what to watch

Tritrichomonas foetus, also proposed as Tritrichomonas blagburni — the same organism, and both names appear on laboratory reports. Compiled from the sources at the foot. This is not a protocol and it does not recommend a dose: it summarizes published evidence so the decision stays with the veterinarian examining the cat.

1 · Patient

Cat
Age / weight
Household cats
Signs since
Stool score (1–7)
Drugs in last 7 days

2 · The test to request

3 · The published dosing history, because it reversed

YearPublished recommendationBasis
200630–50 mg/kg PO q12h × 14 dCleared 10 of 10 experimentally infected cats, PCR-negative 21–30 weeks later; 10 mg/kg failed in all.
2011—PK: oral absorption ≈99.6%, t½ ≈10.5 h, detectable at 48 h. Twice-daily dosing predicted to accumulate.
201330 mg/kg q24h, delayed-release guar gum84% clearance, no adverse events. Not commercially available or readily compoundable.
201430 mg/kg PO q24h × 14 d; q12h withdrawnLetter from the original authors, citing accumulation and neurological toxicity risk.

The 2014 letter stated that the revised once-daily regimen had never been tested for efficacy: it followed from pharmacokinetics, not a treatment trial, and that work still appears outstanding. Ronidazole is not approved for any companion animal and is supplied compounded — capsules, solutions and medicated treats may not be bioequivalent, and the 10% pigeon powder is named in the literature as a cause of apparent failure.

4 · Monitoring — signs that mean stop, not finish

Tremor · ataxia · head tremor · agitation · nystagmus · hyperesthesia · seizures

Neurological signs typically begin at least three days into treatment and usually resolve one to four weeks after the drug is stopped. Continuing after signs appear is what turns a reversible toxicity into a serious one. Many cats that reach this point have already received enough drug to have cleared the infection, which is why retesting afterwards matters. Ronidazole is considered contraindicated in pregnant or lactating queens, and kittens under twelve weeks are usually dosed lower because of immature metabolism.

Handler exposure: ronidazole is a suspected human reproductive and carcinogenic hazard — the reason for the food-animal ban, not a precaution invented for cats. Compounded powder is the highest-exposure form; pregnant, breastfeeding and immunocompromised people should not handle it.

5 · Retest, and what a negative does and does not mean

6 · If treatment fails, work the differential in this order

Confirm failure by testing rather than by persistence of diarrhea: some cats with recurrent diarrhea no longer carry the organism. Then work the differential in order: formulation (compounded product, capsule versus liquid, pigeon powder) → dose and compliance (weight measured, not estimated) → reinfection from an untreated in-contact cat → resistance (documented, rare but real). In the authors' experience, escalating dose or duration in a genuinely resistant cat does not eradicate and increases toxicity risk. Roughly one in four treated cats remained positive on repeat testing.

Sources

  1. Foster DM, Gookin JL, Poore MF, et al. Outcome of cats with diarrhea and T. foetus infection. J Am Vet Med Assoc 2004;225:888–892.
  2. Gookin JL, Copple CN, Papich MG, et al. Efficacy of ronidazole for treatment of feline T. foetus infection. J Vet Intern Med 2006;20:536–543.
  3. Gookin JL, Stauffer SH, Dybas D, Cannon DH. In vivo and in vitro aerobic resistance of feline T. foetus isolates to ronidazole. J Vet Intern Med 2010;24:1003–1007.
  4. LeVine DN, Papich MG, Gookin JL, et al. Ronidazole pharmacokinetics after intravenous and oral immediate-release capsule administration in healthy cats. J Feline Med Surg 2011;13:244–250.
  5. Papich MG, LeVine DN, Gookin JL, et al. Ronidazole pharmacokinetics following delivery of a delayed-release guar gum formulation. J Vet Pharmacol Ther 2013;36:399–407.
  6. LeVine DN, Gookin JL, Papich MG, Davidson GS. Twice-daily dosing of RDZ no longer recommended (letter). J Feline Med Surg 2014;16:198.
  7. Gookin JL, Hanrahan K, Levy MG. The conundrum of feline trichomonosis. J Feline Med Surg 2017;19:261–274.
  8. Hedgespeth BA, Stauffer SH, Gookin JL. Fecal sample collection technique and treatment history with T. foetus PCR results in 1,717 cats. J Vet Intern Med 2020;34:734–741.
  9. ABCD. Guideline for trichomonosis. abcdcatsvets.org — antibacterial withdrawal, treatment options.
Not veterinary advice and not a prescription. Summarized from published sources; every clinical decision, dose and monitoring plan belongs to the veterinarian treating the cat. Reviewer of record: pending
tritrichomonasproject.org/print/for-your-vet